Cita APA (7a ed.)

Sanchez-Solana, B., Wang, D., Qian, X., Velayoudame, P., Simanshu, D. K., Acharya, J. K., & Lowy, D. R. (2021). The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1. BMC.

Cita Chicago Style (17a ed.)

Sanchez-Solana, Beatriz, Dunrui Wang, Xiaolan Qian, Parthibane Velayoudame, Dhirendra K. Simanshu, Jairaj K. Acharya, y Douglas R. Lowy. The Tumor Suppressor Activity of DLC1 Requires the Interaction of Its START Domain with Phosphatidylserine, PLCD1, and Caveolin-1. BMC, 2021.

Cita MLA (8a ed.)

Sanchez-Solana, Beatriz, et al. The Tumor Suppressor Activity of DLC1 Requires the Interaction of Its START Domain with Phosphatidylserine, PLCD1, and Caveolin-1. BMC, 2021.